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ABSTRACT. At present, all available diagnostic antibody detection 
tests for Trypanosoma brucei gambiense human African trypanosomiasis 
are based on predominant variant surface glycoproteins (VSGs), 
such as VSG LiTat 1.5. During investigations aiming at replacement 
of the native VSGs by recombinant proteins or synthetic peptides, 
the sequence of VSG LiTat 1.5 was derived from cDNA and direct 
N-terminal amino acid sequencing. Characterization of the VSG based 
on cysteine distribution in the amino acid sequence revealed an unusual 
cysteine pattern identical to that of VSG Kinu 1 of T. b. brucei. Even 
though both VSGs lack the third of four conserved cysteines typical for 
type A N-terminal domains, they can be classified as type A.
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INTRODUCTION
In mammalian hosts, the entire cell surface of African trypanosomes, including 
the flagellum, is covered by a dense monolayer of variant surface glycoproteins (VSGs). 
This protective coat has several functions, e.g.: 1) it shields the invariant antigens from 
the immune system, 2) antigenic variation through frequent stochastic switching of 
VSG permits trypanosomes to circumvent the specific antibody response that was raised 
against earlier variable antigen types (VAT). The trypanosome genome contains >1000 
VSG genes, but only one is expressed at a time (Berriman et al., 2005). The VSG dimers 
are tethered to the cell surface by two glycosylphosphatidylinositol anchors that may 
allow high packing density and that play a role in correct transportation and recycling 
of the VSG (Ferguson et al., 1988a,b; Engstler et al., 2004, 2007). Each VSG monomer 
contains at least one N-linked oligosaccharide and consists of two domains that are sepa-
rated by a hinge region. On the living trypanosome, the hyper-variable N-terminal do-
main (350-400 residues) is exposed to the immune system while the relatively conserved 
C-terminal domain (40-80 residues) is hidden from it by the intact VSG coat. VSGs 
are classified based on 1) the position of cysteines in the mature protein sequence, 2) 
conserved N-linked glycosylation sites, 3) the C-terminal residue, and 4) the C-terminal 
hydrophobic GPI-anchor signal. The N-terminal domain is classified into three types, A, 
B and C (Carrington et al., 1991), although type C has been proposed to be classified 
as type A (Marcello and Barry, 2007). Despite their high primary sequence heterogene-
ity, all N-terminal domains fold with a similar tertiary structure, necessary to form the 
densely packed protective VSG coat, which exposes only a limited subset of immuno-
genic epitopes (Freymann et al., 1984; Blum et al., 1993; Chattopadhyay et al., 2005; 
Schwede and Carrington, 2010; Schwede et al., 2011). There are six types of C-terminal 
domains; types 2, 4 and 5 are single domains, while types 1, 3 and 6 are di-domains 
(Carrington et al., 1991; Marcello and Barry, 2007; Schwede and Carrington, 2010). The 
type 2 domain of MITat 1.2 and the type 1 domain of ILTat 1.24 share the same tertiary 
structure, arguing for conservation of the tertiary structure of both N- and C-terminal do-
mains (Schwede and Carrington, 2010). All combinations of N-terminal with C-terminal 
domains seem to be possible (Hutchinson et al., 2003).
One of the predominant VSGs of Trypanosoma brucei gambiense, causing the chronic 
form of sleeping sickness or human African trypanosomiasis (HAT), is VSG LiTat 1.5 (Van 
Meirvenne et al., 1995). All currently available antibody detection tests for gambiense HAT, 
i.e., card agglutination test for trypanosomiasis (CATT) (Magnus et al., 1978), LATEX/T. b. 
gambiense and ELISA/T. b. gambiense (Büscher et al., 1999) make use of the native VSGs 
LiTat 1.3, LiTat 1.5 and/or LiTat 1.6. The sequencing of the VSG LiTat 1.5 gene revealed 
that the N-terminal domain can be classified as type A even though the third of four typically 
conserved cysteines is missing. The C-terminal domain is a classical type 2 (Carrington et al., 
1991). 
MATERIAL AND METHODS
VSG LiTat 1.5 was purified from a cloned population of T. b. gambiense VAT LiTat 
1.5 (Büscher et al., 1999). The N-terminal amino acid sequence of the mature VSG LiTat 
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1.5 protein was determined by Edman degradation (Edman, 1950) on an ABI 471-B as 
recommended by the manufacturer. RNA was extracted from the same cloned population 
as above (RNeasy Midi Kit; Qiagen). After removing contaminating DNA (DNA-freeTM 
kit; Ambion), cDNA was prepared by RT-PCR with an oligo(dT)18-primer (Transcriptor 
First-Strand cDNA Synthesis kit; Roche). To amplify the VSG LiTat 1.5 DNA sequence, 
a proofreading DNA polymerase (Deep VentR
TM DNA polymerase; New England Biolabs) 
and oligo 54 (spliced leader) forward primer and oligo 42 (VSG all) reverse primer were 
used (Table 1). The PCR product was purified (QIAquick PCR Purification kit; Qiagen), 
and post-amplification 3ꞌ-adenine ends were added with HotStarTaq® DNA polymerase 
(Qiagen). The resulting construct was ligated into a pCR®2.1-TOPO® vector (TOPO TA 
Cloning® Kit; Invitrogen). These plasmids were transformed by heat-shock (30 s at 42°C) 
into One Shot® TOP10 chemically competent Escherichia coli cells. Clones with VSG 
LiTat 1.5 inserted in the pCR®2.1-TOPO® vector were screened by colony-PCR with the 
M13 forward and reverse primers (Table 1). Five positive colonies were grown for plasmid 
purification with the QIAprep® Spin Miniprep kit (Qiagen). The nucleotide sequence of 
VSG LiTat 1.5, ligated into the pCR®2.1-TOPO® vector, was determined at the VIB Ge-
netic Service Facility of the University of Antwerp by sequencing with the M13 forward 
and reverse primers. The chromatograms were read with Chromas 2.33 (Technelysium Pty 
Ltd.), and five identical DNA sequences were obtained. 
RESULTS AND DISCUSSION
The cDNA and protein sequence of VSG LiTat 1.5 are published in the NIH genetic 
sequence database (GenBank ID: HQ662603). The amino acid sequence of VSG LiTat 1.5 is 
presented in Figure 1. 
Fifty-seven N-terminal amino acids were derived by direct sequencing of the mature VSG 
LiTat 1.5 protein: AAITDADTGPAQITDVxKEEFYLSELRKELAAGITRRRTQRQGLLxIQxxY
RLAADL. The signal sequence was determined by comparison of the amino acids obtained by 
Edman degradation with the sequence derived from cDNA. The N-terminal domain is nominally 
taken to be residue 1 to 350 of the mature VSG. Interestingly, the cysteine distribution in both the 
N- and C-terminal domains of the mature VSG LiTat 1.5 protein is identical to that of VSG Kinu 
1 (GenBank ID: AJ937313.1), even though both proteins share only 33% of identical amino acids 
(Clustal W multiple sequence alignment (Thompson et al., 1994) (Figure 1).
VSG Kinu 1, of a T. b. brucei strain originally collected in the Tororo district of 
Uganda, has been classified as a type A N-terminal domain (Hutchinson et al., 2007; Mar-
cello and Barry, 2007), but when compared to typical type A VSGs such as VSG MITat 
1.2, the third of four conserved cysteines is missing (Carrington et al., 1991). However, 
according to Marcello and Barry (2007), a group 2 subclass and a group 4 of type A also 
 Primer sequence (5ꞌ-3ꞌ)
Oligo 54 (spliced leader) GACTAGTTTCTGTACTAT
Oligo 42 (VSG all) CCGGGTACCGTGTTAAAATATATC
M13 forward primer TGTAAAACGACGGCCAGT
M13 reverse primer CAGGAAACAGCTATGACC
Table 1. Primers used for the amplification and sequencing of LiTat 1.5 cDNA.
VSG = variant surface glycoprotein.
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lack this conserved cysteine around position 123 (Figure 2). Furthermore, the presence of 
cysteine at position 147 is similar to the group 1 cysteine pattern (MITat 1.2 residue 145), 
while the cysteines at positions 17, 65, 214, 250, 272, and 306 show an identical cysteine 
pattern as in group 2 subclass of type A. The extra cysteine residue at position 196 can be 
found in group 4 of type A. Classification of the protein sequences of VSG LiTat 1.5 and 
Kinu 1 is thus not straightforward. As six of eight cysteines are similar to the group 2 sub-
class of type A, they can be classified as type A, but it is also possible that they constitute 
a separate group or subclass.
Figure 1. Alignment of variant surface glycoprotein (VSG) LiTat 1.5 of T. b. gambiense with VSG Kinu 1 of T. b. 
brucei. The amino acid sequence of LiTat 1.5 was deduced from its cDNA sequence (GenBank ID: HQ662603). 
The amino acid residues are numbered starting with the N-terminal end of the mature protein as determined by 
Edman degradation. The result of the Edman degradation is underlined. The amino acid sequence of VSG LiTat 
1.5 is aligned with the sequence of Kinu 1 (Genbank ID: AJ937313.1). The signal sequence is indicated in gray. 
Cysteines are gray and underlined, and their position in the N-terminal domain of the mature protein sequence of 
VSG LiTat 1.5 is numbered. The domain boundary between the nominally determined mature N- and C-terminal 
domains is in italics. The C-terminal hydrophobic sequence is in bold italics. The C-terminal residue is bold and 
underlined. Identical residues are marked with an asterisk under the sequence. Colons indicate strongly conserved 
substitutions (side chains with similar biochemical properties, scoring >0.5 in the Gonnet PAM 250 matrix). Periods 
indicate weakly conserved substitutions (scoring ≤0.5 in the Gonnet PAM 250 matrix). 
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The location of the mature C-terminal domain and C-terminus is based on sequence 
homology (Carrington et al., 1991). The C-terminal domain sequence of both VSG LiTat 1.5 
and VSG Kinu 1 consists of 45 amino acids and belongs to type 2, with four cysteine residues 
(positions 412, 420, 426, and 433) and serine as C-terminal residue. The hydrophobic exten-
sion of VSG LiTat 1.5 and VSG Kinu 1 contains, respectively, 17 and 18 amino acids, starts 
with asparagine and shows sequence homology to the hydrophobic extension of VSG MITat 
1.2 (Carrington et al., 1991). 
In conclusion, the sequence of the predominant VSG LiTat 1.5 of T. b. gambiense 
displays an atypical cysteine pattern in the N-terminal domain, but can nevertheless be clas-
sified as a type A. Furthermore, despite a 33% identical amino acid sequence, VSG LiTat 1.5 
shares an identical distribution of cysteine residues, in both the N- and C-terminal domains, 
with VSG Kinu 1 of T. b. brucei. 
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